Crossmark Global Holdings’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1M Sell
3,485
-160
-4% -$46K 0.02% 607
2025
Q1
$1.12M Buy
3,645
+123
+3% +$37.9K 0.02% 574
2024
Q4
$1.24M Sell
3,522
-62
-2% -$21.9K 0.02% 519
2024
Q3
$1.28M Buy
3,584
+608
+20% +$218K 0.02% 528
2024
Q2
$948K Sell
2,976
-653
-18% -$208K 0.02% 598
2024
Q1
$833K Buy
3,629
+62
+2% +$14.2K 0.02% 673
2023
Q4
$784K Sell
3,567
-455
-11% -$100K 0.02% 674
2023
Q3
$926K Sell
4,022
-104
-3% -$23.9K 0.02% 594
2023
Q2
$1.01M Sell
4,126
-264
-6% -$64.8K 0.02% 585
2023
Q1
$983K Buy
4,390
+134
+3% +$30K 0.02% 588
2022
Q4
$1.18M Buy
4,256
+26
+0.6% +$7.23K 0.03% 524
2022
Q3
$886K Sell
4,230
-38
-0.9% -$7.96K 0.02% 577
2022
Q2
$1.01M Sell
4,268
-880
-17% -$207K 0.03% 563
2022
Q1
$923K Sell
5,148
-500
-9% -$89.6K 0.02% 651
2021
Q4
$1.22M Sell
5,648
-90
-2% -$19.4K 0.03% 566
2021
Q3
$1.06M Buy
5,738
+1,790
+45% +$330K 0.02% 594
2021
Q2
$708K Sell
3,948
-120
-3% -$21.5K 0.02% 742
2021
Q1
$680K Sell
4,068
-30
-0.7% -$5.02K 0.02% 747
2020
Q4
$622K Sell
4,098
-90
-2% -$13.7K 0.02% 752
2020
Q3
$423K Buy
4,188
+130
+3% +$13.1K 0.01% 845
2020
Q2
$491K Buy
4,058
+461
+13% +$55.8K 0.01% 764
2020
Q1
$341K Sell
3,597
-130
-3% -$12.3K 0.01% 789
2019
Q4
$328K Buy
3,727
+60
+2% +$5.28K 0.01% 1059
2019
Q3
$292K Sell
3,667
-180
-5% -$14.3K 0.01% 1068
2019
Q2
$300K Sell
3,847
-160
-4% -$12.5K 0.01% 1099
2019
Q1
$470K Buy
4,007
+70
+2% +$8.21K 0.01% 846
2018
Q4
$429K Sell
3,937
-1,180
-23% -$129K 0.01% 846
2018
Q3
$654K Sell
5,117
-510
-9% -$65.2K 0.02% 783
2018
Q2
$637K Buy
5,627
+160
+3% +$18.1K 0.02% 792
2018
Q1
$614K Sell
5,467
-975
-15% -$110K 0.02% 805
2017
Q4
$953K Buy
6,442
+75
+1% +$11.1K 0.02% 660
2017
Q3
$746K Buy
+6,367
New +$746K 0.02% 741
2016
Q3
$746K Buy
+6,367
New +$746K 0.02% 741